Exploratory Evaluation of Bezlotoxumab on Outcomes Associated With Clostridioides difficile Infection in MODIFY I/II Participants With Cancer

BACKGROUND: The incidence of Clostridioides difficile infection (CDI) is reportedly higher and the cure rate lower in individuals with cancer vs those without cancer. An exploratory post hoc analysis of the MODIFY I/II trials (NCT01241552/NCT01513239) investigated how bezlotoxumab affected the rate...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Open Forum Infect Dis
Main Authors: Cornely, Oliver A, Mullane, Kathleen M, Birch, Thomas, Hazan-Steinberg, Sabine, Nathan, Richard, Bouza, Emilio, Calfee, David P, Ellison, Misoo Chung, Wong, Michael T, Dorr, Mary Beth
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2020
Assuntos:
Major Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7029680/
https://ncbi.nlm.nih.gov/pubmed/32099847
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofaa038
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados